0001104659-20-136862.txt : 20201217
0001104659-20-136862.hdr.sgml : 20201217
20201217161804
ACCESSION NUMBER: 0001104659-20-136862
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201215
FILED AS OF DATE: 20201217
DATE AS OF CHANGE: 20201217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Soria Jean-Charles
CENTRAL INDEX KEY: 0001829580
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38869
FILM NUMBER: 201396327
MAIL ADDRESS:
STREET 1: C/O HOOKIPA PHARMA INC.
STREET 2: 350 FIFTH AVENUE SUITE 7240
CITY: NEW YORK
STATE: NY
ZIP: 10118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HOOKIPA Pharma Inc.
CENTRAL INDEX KEY: 0001760542
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 815395687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 0114318906360
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
4
1
a4.xml
4
X0306
4
2020-12-15
0
0001760542
HOOKIPA Pharma Inc.
HOOK
0001829580
Soria Jean-Charles
C/O HOOKIPA PHARMA INC.
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240
NEW YORK
NY
10118
1
0
0
0
Stock Option (Right to Buy)
11.97
2020-12-15
4
A
0
19200
0
A
2030-12-15
Common Stock
19200
19200
D
25% of this option shall vest and become exercisable on December 15, 2021, with the remainder vesting in 8 equal quarterly installments thereafter.
/s/ Reinhard Kandera, as Attorney-in-Fact
2020-12-17